Home Newsfeeds Benchmark Initiates Coverage On NOV with Hold Rating

Benchmark Initiates Coverage On NOV with Hold Rating

Benchmark analyst Doug Becker initiates coverage on NOV (NYSE:NOV) with a Hold rating.

byBenzinga Newsdesk

August 25, 2022

1 minute read

Benchmark analyst Doug Becker initiates coverage on NOV (NYSE:NOV) with a Hold rating.

B. Riley Responds To Bear Cave Report

By Erica Kollmann

February 16, 12:33 PM

"B. Riley has a perfected first lien security interest in the shares collateralizing its loan (as previously discussed during our December Investor Day and repeatedly communicated since). A simple UCC search refutes any notion that these shares were double pledged," the company stated in response.

RILY

Tiziana Life Sciences Reports 3-Month Neuroimaging Scores In Multiple Sclerosis Patients Receiving Intranasal Foralumab; A Primary Endpoint With Clinical Measures Of EDSS (Disability) And MFIS (Fatigue) Is Currently Underway

By Benzinga Newsdesk

April 25, 10:01 AM

Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced for the first time,

TLSA